Novartis
NVS
NVS
1,175 hedge funds and large institutions have $21.5B invested in Novartis in 2020 Q4 according to their latest regulatory filings, with 145 funds opening new positions, 378 increasing their positions, 436 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,175
Holders Change
+58
Holders Change %
+5.19%
% of All Funds
20.85%
Holding in Top 10
14
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.69%
% of All Funds
0.25%
New
145
Increased
378
Reduced
436
Closed
70
Calls
$245M
Puts
$117M
Net Calls
+$128M
Net Calls Change
+$74.4M
Top Buyers
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$182M |
| 2 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
-$178M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$161M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$107M |
| 5 |
Primecap Management
Pasadena,
California
|
-$72.3M |
